Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s share price rose 10% during trading on Monday . The company traded as high as $0.78 and last traded at $0.7270. Approximately 656,290 shares were traded during mid-day trading, an increase of 30,214% from the average daily volume of 2,165 shares. The stock had previously closed at $0.6610.
Graybug Vision Trading Up 10.0%
The stock has a market cap of $1.14 million, a PE ratio of -0.42 and a beta of 1.20. The business’s 50-day moving average price is $2.85 and its 200-day moving average price is $3.33.
About Graybug Vision
Graybug Vision, Inc is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD).
Read More
- Five stocks we like better than Graybug Vision
- Gold Shock Coming March 18?
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
